Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET/CT Imaging-Based Distinction of Pulmonary Lymphoma and Other Hypermetabolic Lesions Via Imaging Manifestations and Machine Learning Techniques: a Multicenter Retrospective Study

NCT06602674 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06602674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06602674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET/CT Imaging-Based Distinction of Pulmonary Lymphoma and Other Hypermetabolic Lesions Via Imaging Manifestations and Machine Learning Techniques: a Multicenter Retrospective Study
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2024
Completion date
April 30, 2025
Enrollment
647 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign pulmonary diseases, lung cancers, pulmonary lymphomas, pulmonary metastases